PATENT CLAIM ANALYSIS

Application Number: 16171046
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-03
Patent Classification: ["540", "557000"]

Abstract:
Tricyclic and tetracyclic derivatives of benzodiazepine, pyridodiazepine, and pyrimidodiazepine fused with 1,4-dihydropyridine derivatives are disclosed. The present derivatives can be obtained from derivatives containing a dihydropyrldine ring reacting with compounds of the ortho-phenyldiamine, ortho-diaminopyridine, and ortho-diaminopyrimidine type, as well as some subsequent transformations and, tricyclic and tetracyclic derivatives can be obtained with a diazepine or diazepinone nucleus fused to a 1,4-dihydropyridine nucleus, having a substituted or unsubstituted ring of benzene, pyridine or pyrimidine. The present derivatives exhibit vascular and central nervous system therapeutic activity.

Claim (Index 22):
The pharmaceutical composition according to  claim 18  wherein R 2  represents an alkyl.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 97.0
- Lexical Diversity: 1.69643
- Patent Class: 540.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14282111', '13500983', '13397195', '14512059', '12700131']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6826452196307493
- 35 USC 102 Novelty (BERT): 0.5823199472541312
- Combined Prediction Score: 0.6726126923930875
- Mean Citation Score: 339.291398
- Max Citation Score: 545.46277
- Similarity Product: 337.9494190034944

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test